Global Blood Therapeutics, Inc. is a biopharmaceutical company that engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company focuses on acquiring rights to drugs and other products for which there is an unmet need in the treatment of SCD. The company is committed to delivering new, potentially transformative treatments for patients who have few options today.

Latest articles

Four Decades of IPOs: An Overview

An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.

24 Apr 2024

Larry Page: The Mastermind Behind Google

Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.

24 Apr 2024

Mark Leonard: The Mysterious Brain Behind Constellation Software

Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.

24 Apr 2024

Ticker symbol

Country

🇺🇸 United States